| 09th week of 2011 patent applcation highlights part 66 |
| Patent application number | Title | Published |
|---|
| 20110054175 | SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS - Described herein are fluorinated organic compounds and methods of making fluorinated organic compounds, for example, using palladium complexes. Also described herein are compositions and kits containing compounds and palladium complexes described herein. | 2011-03-03 |
| 20110054176 | QUINOLINE-OXAZOLINE COMPOUNDS AND THEIR USE IN OXIDATION SYNTHESIS - A quinoline-oxazoline compound having the formula: | 2011-03-03 |
| 20110054177 | PROCESS FOR PRODUCING 5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-c]PYRIDINE-2-CARBOXYLIC ACID - 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid of formula (5) or a salt thereof, | 2011-03-03 |
| 20110054178 | PROCESS FOR THE MANUFACTURE OF [PHENYLSULFANYLPHENYL]PIPERIDINES - A process for the manufacture of (un)substituted phenylsulfanylphenyl-piperidines comprising the use of benzyl as N-piperidine protecting group is disclosed. | 2011-03-03 |
| 20110054179 | MMP-2 AND/OR MMP-9 INHIBITOR - The present invention provides a highly safe pharmaceutical preparation effective for diseases caused by MMP-2 and/or MMP-9. The pharmaceutical preparation contains, as an active ingredient, at least one member selected from the group consisting of thiazole derivatives represented by Formula (1): | 2011-03-03 |
| 20110054180 | Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst - This invention relates to the use of nano-organocatalysts, and, more specifically, to the use of magnetic nanomaterial-supported organocatalysts. It is an object of the present invention to provide “green” catalysts and protocols. According to one embodiment of the invention, a nano-organocatalyst in the form of a magnetic nanomaterial-supported organocatalyst is provided. According to other embodiments of the invention, glutathione and cysteine are provided as organocatalysts and magnetic nanomaterial-supported glutathione and magnetic nanomaterial-supported cysteine are provided for use as nano-organocatalysts. According to another embodiment of the invention, a method of using a recyclable magnetic nanomaterial-supported organocatalyst using a totally benign aqueous protocol, without using any organic solvent in the reaction or during the workup, is provided. According to a further embodiment of the invention, a recyclable magnetic nanomaterial-supported organocatalyst for various organocatalytic reactions, including but not limited to Paal-Knorr reactions, aza-Michael addition and pyrazole synthesis, is provided. | 2011-03-03 |
| 20110054181 | NEAR INFRARED FLUORESCENT IMAGING AGENT - A compound represented by general formula (I) below, or a pharmacologically acceptable salt thereof: | 2011-03-03 |
| 20110054182 | Novel Process for the Preparation of 4-Aminobut-2-enolides - Process for the preparation of 4-aminobut-2-enolide compounds of the formula (I): | 2011-03-03 |
| 20110054183 | Method For Manufacturing Aryl Carboxamides - A process for preparing arylcarboxamides of the formula (I) | 2011-03-03 |
| 20110054184 | SURFACE TREATMENT AGENT AND SURFACE TREATMENT METHOD - The object is to provide a surface treatment agent that can effectively prevent pattern collapse of an inorganic pattern or resin pattern provided on a substrate, and a surface treatment method using such a surface treatment agent. In addition, as another object, the present invention has an object of providing a surface treatment agent that can carry out silylation treatment to a high degree on the surface of a substrate, and a surface treatment method using such a surface treatment agent. The surface treatment agent used in the surface treatment of a substrate contains a silylation agent and a silylated heterocyclic compound. | 2011-03-03 |
| 20110054185 | PROCESS FOR PRODUCING THIAZOLE COMPOUND - A process for producing a thiazole compound of the formula (3): | 2011-03-03 |
| 20110054186 | PROCESS FOR EPROSARTAN INTERMEDIATE - The present invention provides an improved process for preparation of (E)-α-[[2-butyl-1-[[4-(methoxycarbonyl)phenyl]methyl]-1H-imidazole-5-yl]methylene]-2-thiophene propanoic acid ethyl ester in high purity and in high yield. Thus, for example, 4-[[2-butyl-5-formyl-1H-imidazole-1-yl]methyl]benzoic acid methyl ester is reacted with ethyl 2-carboxy-3-(2-thienyl)propionate in the presence of piperidinium propionate in diisopropyl ether or a mixture of n-hexane and a solvent selected from toluene and cyclohexane, optionally purifying the crude compound to obtain (E)-α-[[2-butyl-1-[[4-(methoxy carbonyl)phenyl]methyl]-1H-imidazole-5-yl]methylene]-2-thiophene propanoic acid ethyl ester substantially free of 3-(2-thienyl)propanoic acid ethyl ester impurity. | 2011-03-03 |
| 20110054187 | DIFLUOROBORADIAZAINDACENE DYES - The invention relates to difluoroboradiazaindacene dyes of the formula (1) | 2011-03-03 |
| 20110054188 | NEAR INFRARED FLUORESCENT IMAGING AGENT - A compound represented by general formula (I) below, or a pharmacologically acceptable salt thereof: | 2011-03-03 |
| 20110054189 | Process For The Synthesis C-2, C-3 Substituted N-Alkylated Indoles Useful As CPLA2 Inhibitors - The present invention provides a compound of formula 1: | 2011-03-03 |
| 20110054190 | CATALYST AND REACTION PROCESS - Disclosed is a technology for enabling an efficient asymmetric Michael addition reaction which does not require a large amount of a malonic ester, while having a short reaction time. Specifically disclosed is a catalyst which is composed of MX | 2011-03-03 |
| 20110054191 | NEW METHODS FOR THE PREPARATION OF TAXANES USING CHIRAL AUXILIARIES - A stereoselective synthesis of novel β-lactam dimers as useful precursors for the preparation of paclitaxel, docetaxel, and analogues thereof. More particularly, the new β-lactams are prepared from readily available and enantiomerically pure chiral auxiliaries. The β-lactams are then reacted with a suitably protected taxane to produce diastereomerically enriched side chain-bearing taxanes. Finally, the chiral auxiliary is cleaved and protecting groups are removed to provide the desired taxane. | 2011-03-03 |
| 20110054192 | PAPER SIZING ADDITIVES, THEIR PREPARATION PROCESS, AND THEIR USE - The present invention pertains to a process for the preparation of an alkenyl-substituted cyclic anhydride compound comprising the steps of subjecting one or more olefinically unsaturated C | 2011-03-03 |
| 20110054193 | STATIN PRODUCTION - The present invention relates to a polypeptide with HMG-CoA reductase activity, to its polynucleotide congener and to a method for the production of a statin comprising over expression of said polypeptide. | 2011-03-03 |
| 20110054194 | Halichondrin B Analogs - The invention includes halichondrin B analogs having pharmaceutical activity; in some cases, crystalline forms thereof, and in some cases, halichondrin B analogs having a further utility as synthetic intermediates. | 2011-03-03 |
| 20110054195 | Synchronized strains of subepidermal cells of muscadine (muscadine sp.) grapevine pericarp for use as a sourse of flavonoids (nutraceuticals) - Methods to generate and isolate novel Synchronized in vitro cell strains of | 2011-03-03 |
| 20110054196 | CATALYST FOR PRODUCTION OF ETHYLENE OXIDE, AND METHOD FOR PRODUCTION OF ETHYLENE OXIDE USING THE CATALYST | 2011-03-03 |
| 20110054197 | METHOD FOR THE PRODUCTION OF EPICHLOROHYDRIN - The invention relates too method for the production of epichlorohydrin, wherein a chloropropane-containing ally chloride in excess is reacted in a first reaction stage with hydrogen peroxide. The non-reacted ally chloride is separated and returned to the reaction, wherein part of the separated ally chloride is added to a second reaction stage and reacted with hydrogen peroxide, wherein the hydrogen peroxide quantity is selected in the second reaction stage such that the ally chloride is largely reacted. The chloropropanes are separated from the reaction mixture of the second reaction stage by means of distillation and removed from the process. | 2011-03-03 |
| 20110054198 | SYNTHESIS OF LONG-CHAIN POLYUNSATURATED FATTY ACIDS BY RECOMBINANT CELLS - The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desaturase or elongase activity that can be used in methods of synthesizing long-chain polyunsaturated fatty acids. | 2011-03-03 |
| 20110054199 | Methods for extracting nutrients, drugs and toxins from a sample, and apparati for same - Provided is a novel method for extracting nutrients, toxins and drugs from a solid sample, comprising adding a solvent such as hexane and isopropanol to said sample, subjecting the sample and solvent to ultrasonic energy, subjecting the sample and solvent to heat, then removing the solvent liquid fraction from what remains of the sample. | 2011-03-03 |
| 20110054200 | Systems and Processes for Biodiesel Production - Described herein are systems and processes for the transesterification of a variety of feedstocks, such as in the form of glyceride-containing vegetable oils, glyceride-containing animal oils, and glyceride-containing algal oils, into biodiesel products using solid, heterogeneous catalysts. | 2011-03-03 |
| 20110054201 | Process for Producing Fatty Acid Esters and Fuels Comprising Fatty Acid Esters - A process for producing fatty acid esters with a high yield from an unrefined natural oil or fat, such as waste oil discarded by restaurant, food industries or common homes. The process comprises reacting an oil or fat with an alcohol in the presence of a titanate catalyst of general formula: Ti(OR) | 2011-03-03 |
| 20110054202 | HEXAFLUORODIMETHYLCARBINOL TERMINATED THIOLS - A hexafluorodimethylcarbinol terminated compound, method of making it, and a composition of matter are disclosed. The compound may have the formula (CF | 2011-03-03 |
| 20110054203 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES - A compound comprising a sulfonated dihydrocarbyl(arylalkyl)phosphine of formula R | 2011-03-03 |
| 20110054204 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES - A compound comprising a class of sulfonated triorganophosphine compounds of formula R | 2011-03-03 |
| 20110054205 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE THEREOF IN HYDROFORMYLATION PROCESSES - A compound comprising a sulfonated triorganophosphine of formula R | 2011-03-03 |
| 20110054206 | METHOD FOR MANUFACTURING DIALKYLZINC AND DIALKYLALUMINUM MONOHALIDE - The present invention is to provide a method for manufacturing dialkylzinc and dialkylaluminum monohalide that makes it possible to efficiently manufacture both dialkylzinc and dialkylaluminum monohalide of high purity and at a high yield on an industrial scale with a single reaction from zinc halide and trialkylaluminum as raw materials, while suppressing the production of precipitants in the reaction process and suppressing the adhesion of precipitates to the equipment and the admixture thereof into the product. | 2011-03-03 |
| 20110054207 | SULFATED PSYLLIUM DERIVATIVE FOR REDUCING THE RISK OF CHRONIC HUMAN DISEASES AND METHOD FOR PREPARING THE SAME - The invention is directed to a method for preparing sulfated psyllium derivatives for use to reduce the risk of chronic human diseases. The sulfation of psyllium was carried out with sulfur, trioxide, pyridine, dimethylformamide and chlorosulfonic acid in pyridine. Six total sulfated psyllium derivatives named SP1, SP2, SP3, SPR1, SPR2, and SPR3 were prepared and evaluated for their morphological and rheological properties, and bile acid-binding abilities. The invention offers a novel approach to obtaining sulfated psyllium derivatives for use in functional foods or supplemental and pharmaceutical products to increase health benefits. | 2011-03-03 |
| 20110054208 | METHOD AND APPARATUS FOR CONTINUOUS FLOW SYNTHESIS OF IBUPROFEN - A multi-step method for the continuous synthesis of ibuprofen or a synthetic precursor of ibuprofen is provided that does not require any intermediate purification or isolation steps and uses reagents compatible with downstream reactions. According to some embodiments, a method is provided wherein isobutylbenzene and a propionyl compound may be converted into a first product in a first Friedel Crafts acylation reaction. The first product may then be converted into a second product in a 1,2-aryl migration reaction. Finally, the second product may be converted into ibuprofen in a hydrolysis reaction. The present invention also provides a method wherein only the first and second reaction steps or only the second and third reaction steps are performed. An apparatus is also provided having two or more microreactors and two or more junctions in particular arrangements for the synthesis of ibuprofen or a synthetic precursor of ibuprofen. | 2011-03-03 |
| 20110054209 | OLEFIN OLIGOMER COMPOSITION - An oligomer of alpha olefin is produced in a three step process comprising 1) oligomerization to a vinylidene, 2) hydroformylation to a primary alcohol, and 3) dimerization of the alcohol. The final product can be hydrogenated to form a branched alkane with improved lubricating oil properties. | 2011-03-03 |
| 20110054210 | Process for Preparing Unsaturated Carboxylic Esters - The invention provides a process for preparing unsaturated carboxylic esters by means of reaction of alkenes having 2 to 6 carbon atoms with alkanecarboxylic acids having 1 to 6 carbon atoms in the presence of an oxygenous gas and in the presence of a heterogeneous noble metal catalyst by means of a continuous homogeneous gas phase process in a reactor, wherein a gaseous phase (cycle gas) is circulated, and the cycle gas is laden with alkanecarboxylic acid in an acid saturator before entry into the reactor, characterized in that, in a presaturator connected upstream of the acid saturator, the cycle gas is laden with a portion of the amount of alkanecarboxylic acid used for saturation, then it is transferred to the acid saturator and laden there with the remaining amount of alkanecarboxylic acid. | 2011-03-03 |
| 20110054211 | PROCESS FOR PRODUCING ISOCYANATES USING DIARYL CARBONATE - An object of the present invention is to provide a process that enables isocyanate to be produced stably over a long period of time and at high yield without encountering problems of the prior art during production of isocyanate without using phosgene. The present invention provides an isocyanate production process including the steps of: obtaining a reaction mixture containing an aryl carbamate having an aryl group originating in a diaryl carbonate, an aromatic hydroxy compound originating in a diaryl carbonate, and a diaryl carbonate, by reacting a diaryl carbonate and an amine compound in the presence of a reaction solvent in the form of an aromatic hydroxy compound; transferring the reaction mixture to a thermal decomposition reaction vessel; and obtaining isocyanate by applying the aryl carbamate to a thermal decomposition reaction, wherein the reaction vessel in which the reaction between the diaryl carbonate and the amine compound is carried out and the thermal decomposition reaction vessel for the aryl carbamate are different. | 2011-03-03 |
| 20110054212 | LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING PROCESS - A lithographic printing plate precursor, which comprises: a support; an image-recording layer; and a protective layer, in this order, wherein at least one of the image-recording layer and the protective layer comprises a phosphonium salt having a specific structure, and a lithographic printing process, which comprises: exposing a lithographic printing plate precursor; supplying an oil-based ink and a fountain solution comprising a phosphonium salt having a specific structure to the exposed lithographic printing plate precursor on a printing machine to remove an unexposed area of an image-recording layer; and conducting printing. | 2011-03-03 |
| 20110054213 | Preparation of acetic acid - A method for reducing aldehydes in an acetic acid production process is disclosed. The acetic acid is produced by reacting methanol and carbon monoxide in the presence of a carbonylation catalyst. The method comprises reacting an aldehyde-containing stream with an alcohol to form an acetal-containing stream. An acetal-enriched stream is separated from the acetal-containing stream and then hydrolyzed to form a hydrolysis mixture comprising the alcohol and the aldehydes. The alcohol is isolated from the hydrolysis mixture and used to react with the aldehyde-containing stream to form the acetal-containing stream. The invention reduces aldehydes in the acetic acid produced. | 2011-03-03 |
| 20110054214 | PROCESS FOR PRODUCTION OF SUPPORTED CATALYST FOR ACETIC ACID PRODUCTION - A process for production of a supported catalyst that, when used for production of lower aliphatic carboxylic acids from oxygen and lower olefins, improves yields of the lower aliphatic carboxylic acids and minimizes production of carbon dioxide gas (CO | 2011-03-03 |
| 20110054215 | PREPARATION OF FREE FLOWING GRANULES OF METHYLGLYCINE DIACETIC ACID - The present invention concerns a process for the preparation of free flowing granules of low hygroscopicity of one or more methylglycine diacetic acid (MGDA) salts, of the formula wherein R=CH3 and M is hydrogen, alkali metal, alkaline earth metal, ammonium or substituted ammonium in the appropriate stoechiometric amounts, by a process comprising the steps of i) heating a concentrated slurry comprising methylglycine diacetic acid (MGDA) and/or any salts thereof, the slurry having a solids content content in the range of 45% to 70% and suitably in the range from 50% to 70%, and a moisture content of 30% up to 55%, and suitably between 30% and 50%, to a temperature in the range of 50 to 120° C., preferably to about 80° C., and ii) spray granulating said slurry, using an air inlet temperature of 120° C. or less. | 2011-03-03 |
| 20110054216 | NOVEL PROCESS FOR MAKING (2R)-(3-AMINO-2-FLUOROPROPYL)PHOSPHINIC ACID FORM A - The present invention is directed to a novel process for the preparation of the crystalline form A of (2R)-(3-amino-2-fluoropropyl)phosphinic acid. | 2011-03-03 |
| 20110054217 | HYDROGENATION OF IMINES - The present invention relates to a process for the asymmetric hydrogenation of imines with hydrogen under elevated pressure in the presence of a catalyst system. In particular the present invention relates to the use of the said catalytic system for the enantioselective hydrogenation of prochiral ketimines to asymmetric amines leading to the formation of herbicides. | 2011-03-03 |
| 20110054218 | Process for the Synthesis of Propargylated Aminoindan Derivatives - A process for preparing a compound of formula (V) or its enantiomer, which comprises:
| 2011-03-03 |
| 20110054219 | PROCESS FOR THE NITRATION OF O-XYLENE AND RELATED COMPOUNDS - Aromatic compounds such as o-xylene are selectively nitrated by nitric acid in the presence of polyphosphoric acid and a large pore, acidic zeolite or a large pore, hydrophobic molecular sieve. This is an environmentally friendly, commercially viable, high conversion process for the selective nitration of aromatic compounds in the para position. | 2011-03-03 |
| 20110054220 | POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES OF LOW RESIDUAL ALDEHYDE CONTENT - The present invention describes a process for preventing the formation of aldehydic contaminants in polyether polyols, polyester polyols or polyurethanes which comprises incorporating into said polyether polyols, polyester polyols or polyurethanes an effective amount of
| 2011-03-03 |
| 20110054221 | PROCESS OF OXIDATIVE CONVERSION OF METHANOL - A process for preparing polyoxymethylene dimethyl ethers from methanol is disclosed. For example, the process comprises contacting methanol with at least one oxidant in the presence of at least one catalyst wherein the at least one catalyst comprises at least one Group VIB metal component, such as in an amount of from about 0.5 to about 50 wt % (in terms of metal oxide) and at least one Group VIII metal component, such as in an amount of from about 0.2 to about 20 wt % (in terms of metal oxide), and at least one molecular sieve having acidic catalytic activity, such as in an amount of from about 40 to about 95 wt %, based on the total weight of the at least one catalyst for a time sufficient to obtain polyoxymethylene dimethyl ethers. | 2011-03-03 |
| 20110054222 | Heterocyclic Amine Catalyst Compositions for the Alkoxylation of Alcohols to Glycol Ethers - Glycol ethers are made by a process in which an alcohol, an alkylene oxide and a catalytic amount of an aromatic, heterocyclic amine catalyst are contacted under reactive conditions. Representative catalysis include substituted and unsubstituted pyridines and imidazoles. The process uses known oxides and alcohols, and produces more mono- and di- adduct products than does a corresponding process using a caustic catalyst. Moreover, the process can be conducted at a lower reaction temperature than a corresponding process using a caustic catalyst without sacrificing oxide conversion rates yet producing fewer carfoonyl impurities. | 2011-03-03 |
| 20110054223 | Method for Purifying Optically Active 1-(2-Trifluoromethylphenyl)Ethanol - There is disclosed a purification method of an optically active 1-(2-trifluoromethylphenyl)ethanol represented by the formula [1], which includes recrystallizing the optically active 1-(2-trifluoromethylphenyl)ethanol from an aliphatic hydrocarbon solvent | 2011-03-03 |
| 20110054224 | PROCESS FOR THE PREPARATION OF ALKYLENE GLYCOL - The invention provides a process for the preparation of an alkylene glycol from an alkene wherein conversion of alkylene oxide to alkylene glycol occurs in an alkylene oxide absorber and optionally in further reactors, and alkylene glycol is extracted from fat absorbent by contacting the fat absorbent with a lean solvent, thereby producing fat solvent, recovering alkylene glycol from the fat solvent and recycling the lean solvent. | 2011-03-03 |
| 20110054225 | METHOD FOR THE PRODUCTION OF FATTY ALCOHOLS - Method for producing fatty alcohols includes splitting vegetable oils and animal fats under pressure into fatty acids and glycerol in counterflow to steam. The reaction product is physically separated into fatty acids and sweet water containing glycerol. The fatty acids are subjected to a distillation, and the separated fatty acid fraction is mixed together with fatty alcohol at 230 to 270° C. and atmospheric pressure. The wax esters obtained by esterification are hydrogenated to fatty alcohols by adding hydrogen on a fixed-bed catalyst, and the reaction product is separated into fatty alcohols and hydrogen. The wax esters are hydrogenated on a fixed bed of uniformly shaped catalyst bodies produced by extrusion, which consist of the main components copper and copper-chromium oxide and the secondary components zinc, aluminum, iron, silicon and alkaline earth elements, at 180 to 220° C. and 70 to 100 bar(a). | 2011-03-03 |
| 20110054226 | Hydrogenation Process for Fluorocarbons - Disclosed is a process and apparatus for the catalytic hydrogenation of fluoroolefins to fluorocarbons where the reaction is carried out in a multi-tube shell and tube reactor. Reactions involving hydrogenation of fluoro-olefins are typically exothermic. In commercial processes where a fluoro-olefin C | 2011-03-03 |
| 20110054227 | Process to Protect Hydrogenation and Isomerization Catalysts Using a Guard Bed - Processes and an apparatus for hydrogenating highly unsaturated hydrocarbons contained in an effluent stream to an unsaturated hydrocarbons or isomerizing the highly unsaturated hydrocarbons to other highly unsaturated hydrocarbons are provided. The effluent stream is contacted with a guard bed to remove at least a portion of impurities contained within the process stream and to isomerize at least a portion of the highly unsaturated hydrocarbons. In an aspect, the guard bed comprises a solid sulfur adsorption/isomerization catalyst composition. In an aspect, the effluent stream is contacted with a catalyst that comprises an inorganic support, palladium, and silver. | 2011-03-03 |
| 20110054228 | BLUE ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME - The present invention relates to novel organic electroluminescent compounds and display devices comprising the same. The organic electroluminescent compounds according to the present invention exhibit high luminous efficiency and excellent life property, so that an OLED device having very good operation life can be prepared therefrom. | 2011-03-03 |
| 20110054229 | LUMINESCENT COMPOUNDS AND ELECTROLUMINESCENT DEVICE USING THE SAME - The present invention relates to organic electroluminescent compounds and organic electroluminescent devices employing the same. More specifically, the invention relates to organic electroluminescent compounds containing an anthracenyl group or an aryl group having an anthracenyl substituent m the aryl ring of fluorene or indenofluorene, as a blue electroluminescent material in an organic electroluminescent layer. The electroluminescent compounds according to the invention exhibit high luminous efficiency and excellent life property, so that an OLED device having very good operation lifetime can be prepared therefrom. | 2011-03-03 |
| 20110054230 | REDUCING HYDROGEN CONSUMPTION IN HYDROTREATING OF BIOCOMPONENT FEEDS - Processes are provided for deoxygenation of a biocomponent feedstock with reduced hydrogen consumption. The biocomponent feedstock can be processed under relatively low hydrogen partial pressures and at a relatively low treat gas ratio compared to the hydrogen need of the feedstock. The relatively low pressure, relatively low treat gas ratio hydroprocessing can result in reduced production of water and carbon monoxide and in increased production of carbon dioxide compared to relatively higher pressure process conditions. | 2011-03-03 |
| 20110054231 | PROCESS FOR THE CONVERSION OF NATURAL GAS TO ACETYLENE AND LIQUID FUELS WITH EXTERNALLY DERIVED HYDROGEN - A process for converting natural gas from which contaminants have been sufficiently removed to acetylene includes heating the purified gas through a selected range of temperature for adequate time or combustion of the purified gas at adequate temperature within a suitable environment during an adequate reaction time to convert a fraction of the gas stream to acetylene, wherein the acetylene is directed for other processes, reactions, and uses. A process for converting natural gas to liquid hydrocarbons by combusting externally derived hydrogen for heating natural gas to a selected range of temperature. A process for converting natural gas to liquid hydrocarbons by reacting conversion products with externally derived hydrogen to form olefins comprising ethylene, and catalytically forming liquid hydrocarbons from the olefins comprising ethylene. | 2011-03-03 |
| 20110054232 | Production of Aromatics from Methane - A catalyst for the conversion of methane to higher hydrocarbons including aromatic hydrocarbons comprises molybdenum or a compound thereof dispersed on an aluminosilicate zeolite, wherein the amount of aluminum present as aluminum molybdate in the catalyst is less than 2700 ppm by weight. | 2011-03-03 |
| 20110054233 | METHOD FOR OLIGOMERIZATION OF ETHYLENE AND REACTOR SYSTEM THEREFOR - The present invention relates to a method and a reactor system, for the oligomerization of ethylene, comprising oligomerizing ethylene in a reactor in the presence of a solvent and a catalyst composition to produce a liquid product stream comprising linear alpha-olefins, solvent and catalyst composition, and deactivating and extracting the catalyst composition in said liquid product stream by mixing it with a polar phase in a dynamic mixing device having rotor and stator elements comprising concentric tool rings. | 2011-03-03 |
| 20110054234 | A Method for Storing Hazardous Materials - Storage containers ( | 2011-03-03 |
| 20110054235 | PACKAGING SYSTEM FOR BRACHYTHERAPY IMPLANT AND CUTTING THEREOF - The present disclosure relates to a thermo formed tray having an upper half and a lower half. The upper half and the lower half define a closed configuration when the upper half and the lower half are substantially adjacent one another and an open configuration when the upper half and the lower half are substantially apart from one another. A predetermined area is provided in at least one of the upper half and the lower half for containing a product in the closed configuration, the product having at least one radioactive seed held in a predetermined seed configuration. At least one cutter guide is contained in the thermo formed tray. | 2011-03-03 |
| 20110054236 | COMPOSITIONS AND METHODS FOR TARGETING TUMORS - The present invention relates to functionalized magnetic nanoparticles. In particular, the present invention provides functionalized magnetic nanoparticles for research and clinical (e.g., targeted treatment) applications. | 2011-03-03 |
| 20110054237 | Methods and Systems for Magnetic Focusing of Therapeutic, Diagnostic or Prophylactic Agents to Deep Targets - Systems and methods are disclosed for trapping or focusing magnetizable particles comprising therapeutic agents at a distance using a dynamic magnetic field and feedback control, to enable the treatment of diseased areas deep inside a patient's body. The methods may be used to diagnose or treat diseased areas deep within a patient, for example tumors of the lungs, intestines, and liver, and is also useful in enhancing the permeability of solid tumors to chemotherapeutic agents. | 2011-03-03 |
| 20110054238 | Titanium ionic/Magnetic Bracelet - A titanium alloy bracelet with embedded magnets and a source of negative ions is presented. The embedded magnets are permanent and arranged in a patented alternation north-south orientation to confer improved magnetic field strength. The titanium bracelet helps to disperse the negative ions produced by the ion source. | 2011-03-03 |
| 20110054239 | Pulsatile Control System for a Rotary Blood Pump - A system for controlling the speed of a rotary blood pump. The system oscillates the speed of the pump to produce pulsed pressure at the outlet of the pump. The speed is oscillated synchronously with the natural cardiac cycle. The natural cardiac cycle is determined using a pulsatility index calculated from the back EMF produced by the pump or an impedance sensor. | 2011-03-03 |
| 20110054240 | Induced Relaxation And Therapeutic Apparatus And Method - An apparatus and method for introducing multisensory stimuli. The apparatus includes an ergonomically contoured seating device, at least one vibrating acoustic device, at least one plate for dispersing vibration throughout the entire seating device, a rotatable mechanism for rotating the seating device. | 2011-03-03 |
| 20110054241 | SOUND ENRICHMENT FOR THE RELIEF OF TINNITUS - A sound enrichment system for provision of tinnitus relief, the sound enrichment system includes a noise generator, at least one signal modulator for random or pseudo-random modulation of a noise signal that is obtained using the noise generator, and an output transducer for conversion of the modulated noise signal to an acoustic signal for presentation to a user. A method of providing a noise enriched sound signal for provision of relief of tinnitus includes generating a randomly or pseudo-randomly modulated noise signal, generating an acoustic noise signal using the modulated noise signal, and presenting the acoustic noise signal to a tinnitus suffering person. | 2011-03-03 |
| 20110054242 | Induced Relaxation And Therapeutic Apparatus And Method - An apparatus and method for introducing multisensory stimuli. The apparatus includes an ergonomically contoured seating device, at least one vibrating acoustic device, at least one plate for dispersing vibration throughout the entire seating device, a rotatable mechanism for rotating the seating device. | 2011-03-03 |
| 20110054243 | Tinnitus rehabiliation device and method - A tinnitus method and device for providing relief to a person suffering from the disturbing effects of tinnitus is described. The method can be implemented entirely in software to spectrally modify an audio signal in accordance with a predetermined masking algorithm which modifies the intensity of the audio signal at selected frequencies. A predetermined masking algorithm is described which provides intermittent masking of the tinnitus wherein, at a comfortable listening level, during peaks of the audio signal the tinnitus is completely obscured, whereas during troughs the perception of the tinnitus occasionally emerges. In practice it has been found that such intermittent masking provides an immediate sense of relief, control and relaxation for the person, whilst enabling sufficient perception of the tinnitus for habituation and long term treatment to occur. Advantageously the predetermined masking algorithm is specifically tailored to the audiometric configuration of the person. For example, the masking algorithm may be partly tailored to the hearing loss characteristic of the person. A tinnitus rehabilitation device used in conjunction with a personal sound reproducing system is also described. | 2011-03-03 |
| 20110054245 | Implantable Device for Controlling Defecation and Related Method - An implantable device for selectively controlling defecation has an outer body defining on one end a flange that is surgically attachable to the person's anus and/or tissue adjacent to the anus. A connector is mounted on the other end of the outer body and is secured to the distal end of the person's large intestine for connecting the large intestine in fluid communication with the device. An inner body is slidably received within the outer body. A macerator-type pump is mounted within the inner body and an inlet valve is mounted between the pump and the connector. An actuator in the form of an RF receiver is electrically coupled to the inlet valve and the pump and a remote transmitter is operatively coupled to the receiver. The receiver is responsive to control signals received from the transmitter to open the inlet valve and operate the pump in order to move fecal matter through the device. | 2011-03-03 |
| 20110054246 | WHOLE GENOME SCAN TO DISCOVER QUANTITATIVE TRAI LOCI (QTL) AFFECTING GROWTH, BODY COMPOSITION, AND REPRODUCTION IN MATERNAL PIG LINES - The present invention provides compositions and methods useful for determining an animal's genotype and to select animals having a desired genotype. Embodiments of the invention also provide isolated nucleic acid molecules and analytical kits that may be used to determine an animal's genotype. Furthermore, the present invention provides methods for improving desirable animal traits including improved growth, enhanced body composition, and improved reproductive traits. The invention also provides methods for allocating animals for predetermined uses, for picking potential parent animals for breeding, and for producing progeny animals. The instant invention also provides methods for identifying associations between single nucleotide polymorphisms (SNPs) and phenotypic traits. Also provided are methods for identifying genetic markers in allelic association with the SNP disclosed herein and for identifying the genotypes of a causative mutation underlying a quantitative trait locus (QTL). | 2011-03-03 |
| 20110054247 | METHODS FOR CLONING FERRETS AND TRANSGENIC FERRET MODELS FOR DISEASES - The invention provides a transgenic Mustelidae in which a gene associated with a human disease or condition comprises a targeted genetic modification, and uses thereof. Also provided is a method to cryopreserve Mustelidae embryos or cells, and to enhance the number of live offspring from cryopreserved Mustelidae embryos. | 2011-03-03 |
| 20110054248 | GASTRIC BAND WITH ELECTRIC STIMULATION - A gastric band system including a functional electrical stimulation component is provided. Stimulation electrodes on the gastric band may be used to stimulate the vagal nerve and/or splanchnic nerve, which can inhibit the patient's appetite. The gastric band may have an inflatable member for adjusting a stoma size. The stimulation electrodes may be mounted on the inflatable member. The system may include a controller including a pressure sensor for monitoring the hydraulic pressure within the inflatable inner member and for controlling the stimulation component. | 2011-03-03 |
| 20110054249 | APPARATUS, SYSTEM AND METHOD OF MINIMALLY INVASIVE REPAIR OF PELVIC ORGAN PROLAPSE - A system for repair of a prolapsed organ in a patient includes a support and a deployment instrument having a handle extending from a barrel and a trigger offset from the handle, the trigger is operable to advance the support out of the barrel of the deployment instrument and into the patient. | 2011-03-03 |
| 20110054252 | ENDOSCOPE HAVING OPTICAL FIBERS - An endoscope for image pickup of an object by receiving image light with an image sensor includes an elongated tube. A fiber optic image guide includes a plurality of optical fibers being bundled, and has a distal tip, is inserted through the elongated tube, for transmitting the image light focused on the distal tip by an objective lens system in a proximal direction. A piezoelectric actuator is disposed on an outer side of the fiber optic image guide, for periodically displacing the distal tip, wherein the image sensor picks up the image light from the fiber optic image guide for plural times in synchronism with displacement, to form one synthesized image. A hood device is mounted on a head assembly of the elongated tube, and shiftable between a closed position for covering a distal end face of the head assembly and an open position for revealing the distal end face. | 2011-03-03 |
| 20110054253 | METHOD AND DEVICE FOR AUTOMATED TRANSLATIONAL MOVEMENT OF AN ENDOSCOPE THROUGH THE DIGESTIVE TRACT - Device for automated translational movement of an endoscope through the digestive tract, comprising, at least: (i) pneumatic translational movement means; and (ii) electronic control means, that enable the automated and coordinated method of the translational movement means. The translational movement means include: at least one radial chamber immobilized on the endoscope; at least one bellows-shaped axial chamber connected via one end to the body of the endoscope; at least one radial chamber floating on the endoscope and secured to the second end of the bellows-shaped axial chamber. | 2011-03-03 |
| 20110054254 | COIL ARRANGEMENT FOR GUIDING A MAGNETIC ELEMENT IN A WORKING SPACE - A coil arrangement for contact-free guidance of a magnetic element such as an endoscopy capsule, has a number of individual coils arranged in pairs by which the components of a guidance field are generated. By arranging the individual coils to include coils corresponding to blades at an exterior of a cylindrical surface, the number of degrees of freedom required for guidance can be obtained with fewer individual coils and fewer power amplifiers to operate the coils. | 2011-03-03 |
| 20110054255 | METHOD FOR CONTROLLING THE MOVEMENT OF AN ENDOSCOPIC CAPSULE - In a method to control the movement of an endoscopy capsule in a hollow organ of a patient using a magnet system, a movement signal of the endoscopy capsule in the hollow organ is detected, that represents the time curve of the spatial position. The movement signal is evaluated to identify a periodic signal component thereof, and the frequency of this periodic signal component is identified. The magnet system is operated to exert a force on the endoscopy capsule in the hollow organ that is periodic with the frequency of the periodic signal component, and that is directed opposite to the movement signal. | 2011-03-03 |
| 20110054256 | IN-LINE GAS ADAPTOR FOR ENDOSCOPIC APPARATUS - The present invention provides an adaptor that is suitable for attachment to an endoscopic device for delivery of a secondary gas. The adaptor generally comprises an adaptor body with first and second fluid transport components and can include a gas inlet on one of the fluid transport components suitable for attachment to a secondary gas source. A sealing member can be included to prevent leakage of any fluid (e.g., liquid or gas) that is transported through channels extending through the fluid transport components. The adaptor may be used in endoscopy methods and is particularly useful for adding a secondary gas source in an endoscopy procedure. | 2011-03-03 |
| 20110054257 | SINGLE INCISION SURGICAL PORTAL APPARATUS INCLUDING INNER MEMBER - A surgical apparatus includes a housing member and an inner member. The housing member includes an expandable material that is adapted to transition between a compressed condition and an expanded condition. In the expanded condition, an outer surface of the housing member is adapted for a substantial sealing relationship with tissue upon insertion of the housing member within the tissue for accessing an underlying tissue site. The housing member has leading and trailing ends that define a longitudinal axis. The inner member is operably associated with the housing member and includes one or more longitudinal portals extending therethrough adapted for substantially sealed reception of a surgical object. The inner member may be less compliant than the housing member. The inner member may rotate about the longitudinal axis of the housing member. | 2011-03-03 |
| 20110054258 | FOAM PORT INTRODUCER - The present disclosure relates to devices for introducing a port within a body cavity. The system includes a compressible port that collapses radially for positioning into an introducer that is inserted into an incision. Methods for using the devices are also described. | 2011-03-03 |
| 20110054259 | MINIMALLY INVASIVE RETRACTOR AND METHODS OF USE - A device, system and method for orthopedic spine surgery using a novel screw-based retractor, disclosed herein, that allows for access to the spine through a minimally or less invasive approach. The retractor device is designed to be coupled to a pedicle screw and then to have opposed arms of the retractor spread apart to open the wound proximally. The retractor is removed by pulling it out of the wound whereby the retractor is deformed to pass over the pedicle screw head. The retractor is intended to be made of a stiff plastic material, sterile packaged and disposable after one use. A system and method for using the retractor and performing a minimally invasive spine surgical procedure are also disclosed. | 2011-03-03 |
| 20110054260 | MULTI-FUNCTIONAL SURGICAL ACCESS SYSTEM - A surgical access system comprises a wound retractor comprising an outer anchor, an inner anchor, and a flexible, tubular sheath extending therebetween. Embodiments of the outer anchor comprise an outer ring rotatable around an annular axis thereof, thereby rolling the sheath therearound when retracting an incision or opening in a body wall. The sheath comprises a plurality of fibers or strands that improve the abrasion and puncture resistance thereof. Consequently, the surgical access system is useful in procedures in which damage to the sheath is likely, for example, orthopedic hip replacement, and spinal procedures. In some embodiments, the sheath tapers from the outer ring to the inner ring. | 2011-03-03 |
| 20110054261 | Surgical portal apparatus including gear and lockout assembly - A surgical portal apparatus includes a portal, a seal, a plurality of restricting members, and a lockout assembly. The portal defines a longitudinal axis and has a longitudinal opening. The seal is disposed in mechanical cooperation with the portal and defines a passage for reception of a surgical object. The plurality of restricting members are arranged about the longitudinal axis to define a passage therethrough and positioned to contact the surgical object. The restricting members have contacting segments adapted for radial movement relative to the longitudinal axis from a rest position to a displaced position. The lockout assembly includes a locking member disposed distal of the restricting members. The locking member is positioned to intersect the longitudinal opening and engage the surgical object. The locking member is operatively coupled with the restricting members to minimize offset manipulation of the surgical object. | 2011-03-03 |
| 20110054262 | APPARATUS AND METHOD FOR RETRACTION OF TISSUE - A self-retaining retractor and surgical method of retracting integument at a surgical site comprising a medial arm moveably connected to a first end of an extension arm. The extension arm is connected to a lateral arm. The connection may be made after the medial arm is in the surgical site. The extension arm may be moved from an undeployed position to a deployed position. The medial arm or the lateral arm may include a surgical instrument holder, such as a holder for an endoscope. A locking mechanism may be used to lock the retractor in a deployed position. A strap may also be used to secure the retractor. | 2011-03-03 |
| 20110054263 | Replaceable LED illumination assembly for medical instruments - A replaceable LED assembly for medical instruments and medical devices including at least one LED(light emitting diode) to be used with the medical instruments that are using incandescent lamps or xenon lamps as illumination source. This LED illumination assembly will also allow exchange of LED lamp's without the use of heat, solder, mechanical tools or physical force beyond the use of hand pressure. | 2011-03-03 |
| 20110054264 | Systems and methods of alarm validation and backup in implanted medical devices - Alarm tests are disclosed which use alarm test signals to assess alarms provided by medical devices. Especially relevant are implanted devices that monitor cardiac activity and provide notification in response to medically relevant events. Alarm tests can occur periodically, or in response to a patient, doctor, or remote party initiating the alarm test. Alarm tests can also occur during the actual alarms issued to detected medical events. Alarm tests lead to pass or fail results, which in turn may cause operations to contingently occur. Alarm test failure in the auditory, visual, or tactile modality, may cause an alternatively defined alarm signal to be used as back-up. Alarm test logs can store alarm test results, including quantification of the measured alarm signal. Rapid alarm tests are described, as are various methods of accurately measuring characteristics of the test signal in ambulatory patients, which are especially relevant to a vibration alarm. | 2011-03-03 |
| 20110054265 | HIGHLY RELIABLE INGESTIBLE EVENT MARKERS AND METHODS FOR USING THE SAME - Ingestible event markers having high reliability are provided. Aspects of the ingestible event markers include a support, a control circuit, a first electrochemical material, a second electrochemical material and a membrane. In addition, the ingestible event markers may include one or more components that impart high reliability to the ingestible event marker. Further, the ingestible event markers may include an active agent. In some aspects, the active agent, such as a pharmaceutically active agent or a diagnostic agent may be associated with the membrane. | 2011-03-03 |
| 20110054266 | METHOD FOR PROTOCOL CREATION IN A DIAGNOSTIC IMAGING SYSTEM - A method of exam protocol creation in a diagnostic imaging system includes initiating a non-protocol diagnostic imaging exam with the diagnostic imaging system. Concurrently with implementation of the initiated non-protocol diagnostic imaging exam, procedural characteristics of the non-protocol diagnostic imaging exam are recorded, wherein recording includes automatic system recording. In addition, the method includes defining a diagnostic imaging exam protocol in response to the recorded procedural characteristics of the non-protocol diagnostic imaging exam. Defining includes producing an automatic system generated definition of the diagnostic imaging exam protocol as a function of information extracted from the recorded procedural characteristics. | 2011-03-03 |
| 20110054267 | MODULES FOR MONITORING PATIENTS AND RELATED SYSTEMS AND METHODS - Patient monitoring systems can include a display unit and a patient parameter module. The patient parameter module can be connected to a docking region so as to communicate with the display unit in two or more orientations. | 2011-03-03 |
| 20110054268 | DISPLAY UNITS FOR USE IN MONITORING PATIENTS AND RELATED SYSTEMS AND METHODS - Patient monitoring systems can include a docking station and a display unit. The display unit can be coupled with the docking station or decoupled from the docking station. Some display units can include one or more actuators that aid in decoupling the display unit from the docking station that can be actuated while the display unit is being gripped. | 2011-03-03 |
| 20110054269 | METHOD AND APPARATUS FOR PROVIDING AND SHARING COMPREHENSIVE HEALTH INFORMATION - A method and apparatus for providing life health information is provided. The method includes obtaining life health information based on at least one of a physical health state of a person, a psychological health state of the person, and interactive exchange information between the person and other people; setting a personal metaphor that visualizes the life health information of the person; and displaying a visualized image corresponding to the personal metaphor. | 2011-03-03 |
| 20110054270 | Multimodal Method And System For Transmitting Information About A Subject - The present invention is directed to multimodal communications means for transmitting signals representing physiological, performance, and contextual information associated with a subject. In an exemplary embodiment, the multimodal communications means includes multiple radio subsystems (or modes) that enable connection to an external monitoring device to be acquired in a wide range of settings where a single radio mode would be ineffective. Additionally, combining the multimodal communications means of the invention with real-time data-processing allows the communications functionality to be engaged only when data determined to be relevant to the user is identified. | 2011-03-03 |
| 20110054271 | Noninvasive Method And System For Monitoring Physiological Characteristics - Monitoring systems for noninvasively monitoring physiological parameters of a subject, including (i) a wearable monitoring garment adapted to cover at least a portion of a subject's torso, and (ii) a magnetometer system that is embedded in the monitoring garment, the magnetometer system including at least paired first transmission and receiver magnetometers and paired second transmission and receiver magnetometers, the magnetometer system being responsive to changes in distance between the paired magnetometers. | 2011-03-03 |
| 20110054272 | Method And System For Monitoring Physiological And Athletic Performance Characteristics Of A Subject - The present invention is directed to systems and methods for monitoring characteristics of a subject. A system according to an exemplary embodiment of the invention includes a sensor subsystem including at least one respiratory sensor disposed proximate to the subject and configured to detect a respiratory characteristic of the subject, wherein the sensor subsystem is configured to generate and transmit at least one respiratory signal representing the respiratory characteristic, and at least one physiological sensor disposed proximate to the subject and configured to detect a physiological characteristic of the subject, wherein the sensor subsystem is configured to generate and transmit at least one physiological signal representing the physiological characteristic, and a processor subsystem in communication with the sensor subsystem, the processor subsystem being configured to receive at least one of the at least one respiratory signal and the at least one physiological signal. | 2011-03-03 |
| 20110054273 | HEALTH CARE DEVICE - Embodiments described herein relate to health monitoring apparatuses, systems and methods that allow a user to passively monitor her/his health. Embodiments include acquiring chemical substances from a subject's skin (e.g., in sweat and/or sweat vapor or oil excretions) using a sample capture system located on a mounting portion in a fixed location. Embodiments also include analyzing chemical substance(s) acquiring from the subject's skin to generate raw data. Embodiments further include analyzing the raw data to generate health status data for a particular subject. | 2011-03-03 |
| 20110054274 | DEVICE AND METHOD FOR WITHDRAWING BODY FLUID - The invention relates to a device for removing body fluid with a puncture element that can puncture the skin of a body part. The device includes a housing structure for body fluids obtained from the skin puncture and a puncture drive for a back and forth movement of the puncture element. The duration of withdrawal movement is longer than the duration of the forward movement. The puncture drive is designed to withdraw the puncture element in a first withdrawal phase of the withdrawal movement with a maximum withdrawal speed of more than 0.02 m/s. A second retraction phase follows the first retraction phase. Body fluid is collected during the second retraction phase, which has a duration of between 0.3 and 0.8 seconds and/or a retraction speed of between 0.6 and 2 mm/s. | 2011-03-03 |
| 20110054275 | Mounting Unit Having a Sensor and Associated Circuitry - Disclosed herein is a mounting unit assembly that includes a mounting unit and a sensor integrally formed with the mounting unit such that the mounting unit and sensor form a single unit. | 2011-03-03 |
| 20110054276 | METHOD OF MONITORING AN AUTOMATED POINT-OF-CARE FLUID TESTING SYSTEM - A method of monitoring performance of a fluid testing system is provided. The method draws a fluid sample to the testing system using a pump. A voltage output of a sensor, such as an optical sensor, is generated. The voltage output of the optical sensor during the drawing is compared to an upper fluid volume drawn based voltage limit and a lower fluid volume drawn based voltage limit stored within a memory. The system is flushed with a flushing fluid using the pump to flush the flushing fluid from the testing system. The voltage output of the optical sensor during the flushing is compared to an upper fluid volume flushed based voltage limit and a lower fluid volume flushed based voltage limit stored within the memory. An alert generates if at least one of the voltage output during the drawing of the fluid sample is outside of voltage limits. | 2011-03-03 |
| 20110054277 | CONTACTLESS RESPIRATION MONITORING OF A PATIENT AND OPTICAL SENSOR FOR A PHOTOPLETHYSMOGRAPHY MEASUREMENT - The invention also relates to an optical sensor for a photoplethysmography measurement, comprising a light unit | 2011-03-03 |
